The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
SIRT1 Protects against Microglia-dependent Amyloid-β Toxicity through Inhibiting NF-κB Signaling
Open accessAbstract
Accumulating evidence suggests that neurodegeneration induced by pathogenic proteins depends on contributions from surrounding glia. Here we demonstrate that NF-kappaB signaling in microglia is critically involved in neuronal death induced by amyloid-beta (Abeta) peptides, which are widely presumed to cause Alzheimer disease. Constitutive inhibition of NF-kappaB signaling in microglia by expression of the nondegradable IkappaBalpha superrepressor blocked neurotoxicity, indicating a pivotal role for microglial NF-kappaB signaling in mediating Abeta toxicity. Stimulation of microglia with Abeta increased acetylation of RelA/p65 at lysine 310, which regulates the NF-kappaB pathway. Overexpression of SIRT1 deacetylase and the addition of the SIRT1 agonist resveratrol markedly reduced NF-kappaB signaling stimulated by Abeta and had strong neuroprotective effects. Our results support a glial loop hypothesis by demonstrating a critical role for microglial NF-kappaB signaling in Abeta-dependent neurodegeneration. They also implicate SIRT1 in this pathway and highlight the therapeutic potential of resveratrol and other sirtuin-activating compounds in Alzheimer disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a recent study it was found that over expression of SIRT1 deacetylase and SIRT1 activation by resveratrol significantly protects against microglia-dependent amyloid-β toxicity by inhibiting NF-kB signaling199.”
From Mitochondrial Approaches for Neuroprotection (2008) · cites this paper as [199]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 5,882
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,690
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors
Lois, C., Hong, E. J., Pease, S., Brown, E. J., & Baltimore, D. (2002) · Science · doi:10.1126/science.1067081 · Cited by 1,992
Control of IκB-α Proteolysis by Site-Specific, Signal-Induced Phosphorylation
Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., & Siebenlist, U. (1995) · Science · doi:10.1126/science.7878466 · Cited by 1,434
Mammalian SIRT1 Represses Forkhead Transcription Factors
Motta, M. C., Divecha, N., Lemieux, M. E., Kamel, C., Chen, D., Gu, W. J., Bultsma, Y., McBurney, M. W., & Guarente, L. (2004) · Cell · doi:10.1016/s0092-8674(04)00126-6 · Cited by 1,366
Flagged first, then by citations
1 of the 54 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Walker, 2002, Curr. Opin. Investig. Drugs, 3, 782
- Chen, 2005, Mol. Cell. Biol.
Cited by
Sorted by citations
Items 301–400 of 743
Vuong, B., Hogan-Cann, A. D., Alano, C. C., Stevenson, M., Chan, W., Anderson, C. M., Swanson, R. A., & Kauppinen, T. M. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0448-8 · Cited by 71
Alzheimer's disease and epigenetic diet
Sezgin, Z., & Dinçer, Y. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.09.012 · Cited by 69
Dietary natural products as epigenetic modifiers in aging-associated inflammation and disease
Evans, L. W., Stratton, M. S., & Ferguson, B. S. (2020) · Natural Product Reports · doi:10.1039/c9np00057g · Cited by 71
Pérez‐Pinzón, M. A., & Koronowski, K. B. (2015) · Brain Circulation · doi:10.4103/2394-8108.162532 · Cited by 71
Sirtuin modulators control reactive gliosis in an in vitro model of Alzheimer’s disease
Scuderi, C., Stecca, C., Bronzuoli, M. R., Rotili, D., Valente, S., Mai, A., & Steardo, L. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00089 · Cited by 69
Kim, Y. A., Kim, G., Park, K.-Y., & Choi, Y. H. (2007) · Journal of Medicinal Food · doi:10.1089/jmf.2006.143 · Cited by 70
Bao, J., & Sack, M. N. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0402-y · Cited by 67
Kim, M. J., Kim, D. W., Park, J. H., Kim, S. J., Lee, C. H., Yong, J., Ryu, E. J., Cho, S. B., Yeo, H. J., Hyeon, J., et al. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.06.005 · Cited by 67
Anti-inflammatory and Immune Therapy for Alzheimers Disease: Current Status and Future Directions
Walker, D., & Lue, L.-F. (2007) · Current Neuropharmacology · doi:10.2174/157015907782793667 · Cited by 66
Zhang, M., & Ying, W. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7445 · Cited by 70
Yoon, Y. K., Ali, M. A., Wei, A. C., Shirazi, A. N., Parang, K., & Choon, T. S. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.06.060 · Cited by 66
Calorie restriction and stroke
Manzanero, S., Gelderblom, M., Magnus, T. U., & Arumugam, T. V. (2011) · Experimental & Translational Stroke Medicine · doi:10.1186/2040-7378-3-8 · Cited by 65
Yan, J., Luo, A., Gao, J., Tang, X., Zhao, Y., Zhou, B., Zhou, Z., & Li, S. (2019) · Europe PMC (PubMed Central) · Cited by 65
Oxidative Stress and NAD+ in Ischemic Brain Injury: Current Advances and Future Perspectives
Ying, W., & Xiong, Z. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791299911 · Cited by 64
Functional Aspects of Redox Control During Neuroinflammation
Rosales‐Corral, S., Reiter, R. J., Tan, D., Ortiz, G. G., & López-Armas, G. D. C. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2629 · Cited by 66
Mishra, P., Mittal, A. K., Kalonia, H., Madan, S., Ghosh, S., Sinha, J. K., & Rajput, S. K. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200729111744 · Cited by 70
Therapeutic potential of natural molecules against Alzheimer's disease via SIRT1 modulation
Zhang, M., & Tang, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114474 · Cited by 68
Pizzi, M., Sarnico, I., Lanzillotta, A., Battistin, L., & Spano, P. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06767.x · Cited by 63
Huang, J., Huang, N., Xu, S., Luo, Y., Li, Y., Jin, H. D., Yu, C., Shi, J., & Jin, F. J. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108552 · Cited by 66
New role of silent information regulator 1 in cerebral ischemia
Yang, Y., Duan, W., Li, Y., Yan, J., Yi, W., Liang, Z., Wang, N., Yi, D., & Jin, Z. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.06.008 · Cited by 64
Brain response to calorie restriction
Fusco, S., & Pani, G. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1223-y · Cited by 68
Frontal Cortex Epigenetic Dysregulation During the Progression of Alzheimer’s Disease
Mahady, L. J., Nadeem, M., Malek‐Ahmadi, M. H., Chen, K., Perez, S. E., & Mufson, E. J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171032 · Cited by 61
Central role of TRAF-interacting protein in a new model of brain sexual differentiation
Krishnan, S., Intlekofer, K. A., Aggison, L. K., & Petersen, S. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906293106 · Cited by 61
Couturier, J., Paccalin, M., Morel, M., Terro, F., Milin, S., Pontcharraud, R., Fauconneau, B., & Page, G. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-72 · Cited by 65
Dietary Phytochemicals in Neuroimmunoaging: A New Therapeutic Possibility for Humans?
Corbi, G., Conti, V., Davinelli, S., Scapagnini, G., Filippelli, A., & Ferrara, N. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00364 · Cited by 63
Cieślik, M., Czapski, G. A., Wójtowicz, S., Wieczorek, I., Wencel, P. L., Strosznajder, R. P., Jaber, V. R., Lukiw, W. J., & Strosznajder, J. B. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01819-y · Cited by 61
Centeno-Baez, C., Dallaire, P., & Marette, A. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00530.2010 · Cited by 60
Pavlová, S., Klucska, K., Vašíček, D., Ryban, L., Harrath, A. H., Alwasel, S. H., & Sirotkin, A. V. (2013) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2013.06.013 · Cited by 59
Kauppinen, T. M., Gan, L., & Swanson, R. A. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.04.005 · Cited by 64
Self-citationSirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1
Catoire, H., Pasco, M. Y., Abu‐Baker, A., Holbert, S., Tourette, C., Brais, B., Rouleau, G. A., Parker, J. A., & Néri, C. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn109 · Cited by 65
After the grape rush: Sirtuins as epigenetic drug targets in neurodegenerative disorders
Huber, K., & Superti‐Furga, G. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.01.018 · Cited by 60
Yang, H. S., Hu, J., Chen, Y., & Ge, B. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.04.006 · Cited by 60
Vikal, A., Maurya, R., Bhowmik, S., Khare, S., Raikwar, S., Patel, P., & Kurmi, B. D. (2024) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2024.100047 · Cited by 63
Hu, M., Schurdak, M. E., Puttfarcken, P. S., Kouhen, R. E., Gopalakrishnan, M., & Li, J. (2007) · Brain Research · doi:10.1016/j.brainres.2007.03.051 · Cited by 60
SIRT1 as a therapeutic target for Alzheimer’s disease
Wong, S. Y., & Tang, B. L. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0023 · Cited by 59
Liu, S., Li, D., Zeng, H.-Y., Kan, L.-Y., Zou, W., Zhang, P., Gu, H., & Tang, X. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx030 · Cited by 58
Bigford, G. E., & Rossi, G. D. (2014) · Advances in Nutrition · doi:10.3945/an.113.005264 · Cited by 61
Fernando, K., & Wijayasinghe, Y. S. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.746631 · Cited by 57
Sarmah, D., Datta, A., Kaur, H., Kalia, K., Borah, A., Rodriguez, A., Yavagal, D. R., & Bhattacharya, P. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10315-7 · Cited by 59
Yoon, Y. K., Ali, M. A., Wei, A. C., Choon, T. S., Osman, H., Parang, K., & Shirazi, A. N. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.12.029 · Cited by 60
El-kott, A. F., Abd-Lateif, A.-E.-K. M., Khalifa, H. S., Morsy, K., Ibrahim, E. H., Bin-Jumah, M. N., Abdel‐Daim, M. M., & Aleya, L. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.138832 · Cited by 59
Prasanth, M. I., Sivamaruthi, B. S., Cheong, C. S. Y., Verma, K., Tencomnao, T., Brimson, J. M., & Prasansuklab, A. (2024) · Antioxidants · doi:10.3390/antiox13050606 · Cited by 65
Sirtuin modulators: an updated patent review (2012 – 2014)
Mellini, P., Valente, S., & Mai, A. (2014) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2014.982532 · Cited by 60
The SIRT1 Modulators AROS and DBC1 Regulate HSF1 Activity and the Heat Shock Response
Raynes, R., Pombier, K. M., Nguyen, K., Brunquell, J., Mendez, J. E., & Westerheide, S. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054364 · Cited by 62
The role of glial cells in Alzheimer disease: potential therapeutic implications
Cabezas, I. L., Batista, A. H., & Rol, G. P. (2014) · Neurología (English Edition) · doi:10.1016/j.nrleng.2012.10.009 · Cited by 57
Spires‐Jones, T. L., Fox, L. M., Rozkalne, A., Pitstick, R., Carlson, G. A., & Kazantsev, A. G. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00042 · Cited by 57
Silveira, A. C. S., Dias, J. P., Santos, V. M., Oliveira, P. F., Alves, M. G., Rato, L., & Silva, B. M. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180803162059 · Cited by 61
Linking SIRT2 to Parkinson’s Disease
Garske, A. L., Smith, B. C., & Denu, J. M. (2007) · ACS Chemical Biology · doi:10.1021/cb700160d · Cited by 59
Mahmoud, A. M., El‐Ghafar, O. A. M. A., Alzoghaibi, M. A., & Hassanein, E. H. M. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119600 · Cited by 56
Characterization of Nuclear Sirtuins: Molecular Mechanisms and Physiological Relevance
Toiber, D., Sebastián, C., & Mostoslavsky, R. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-21631-2_9 · Cited by 57
SIRT1 Regulates CD40 Expression Induced by TNF-a via NF-?B Pathway in Endothelial Cells
Yang, L., Zhang, J., Yan, C., Zhou, J., Lin, R., Lin, Q., Wang, W., Zhang, K., Yang, G., Bian, X., et al. (2012) · Cellular Physiology and Biochemistry · doi:10.1159/000343318 · Cited by 56
Deng, Z., Jin, J., Wang, Z., Wang, Y., Gao, Q., & Zhao, J. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s124661 · Cited by 56
Liao, D., Chen, Y., Guo, Y., Wang, C., Liu, N., Gong, Q., Fu, Y., Fu, Y., Cao, L., Yao, D., et al. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s249363 · Cited by 56
Role of sirtuins in chronic obstructive pulmonary disease
Chun, P. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0494-2 · Cited by 56
Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology
Guo, J., Cheng, J., North, B. J., & Wei, W. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.07.001 · Cited by 55
Histone deacetylases as targets for the treatment of human neurodegenerative diseases
D’Mello, S. R. (2009) · Drug News & Perspectives · doi:10.1358/dnp.2009.22.9.1437959 · Cited by 53
Extracellular Vesicles miRNA Cargo for Microglia Polarization in Traumatic Brain Injury
Panaro, M. A., Benameur, T., & Porro, C. (2020) · Biomolecules · doi:10.3390/biom10060901 · Cited by 56
McCarty, M. F., Assanga, S. B. I., Luján, L. M. L., O’Keefe, J. H., & DiNicolantonio, J. J. (2020) · Nutrients · doi:10.3390/nu13010047 · Cited by 55
Small molecule modulators of chromatin remodeling: from neurodevelopment to neurodegeneration
Jiang, D., Li, T., Guo, C., Tang, T.-S., & Liu, H. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-00953-4 · Cited by 54
Fan, J., Guang, H., Zhang, H., Chen, D., Ding, L., Fan, X., Xue, F., Gan, Z., Wang, Y., Mao, S., et al. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.04.013 · Cited by 55
Ortega, R. H., Costa, G. D., Cerezo, A. B., Troncoso, A. M., Richard, T., & García-Parrilla, M. C. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700383 · Cited by 54
Qian, Y., Xin, Z., Lv, Y., Wang, Z., Zuo, L., Huang, X., Li, Y., & Xin, H.-B. (2017) · Food & Function · doi:10.1039/c7fo01442b · Cited by 55
Cao, K., Dong, Y., Xiang, J., Xu, Y., Hong, W., Song, H., & Guan, Z.-Z. (2018) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2018-205320 · Cited by 53
Tyrosol as a Neuroprotector: Strong Effects of a “Weak” Antioxidant
Плотников, М. Б., & Плотникова, Т. М. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200507082311 · Cited by 52
Immunomodulatory Role of Nutrients: How Can Pulmonary Dysfunctions Improve?
Gozzi-Silva, S. C., Teixeira, F. M. E., Duarte, A. J. D. S., Sato, M. N., & Oliveira, L. D. M. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.674258 · Cited by 55
Sirtuins Expression and Their Role in Retinal Diseases
Balaiya, S., Abu‐Amero, K. K., Kondkar, A. A., & Chalam, K. V. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3187594 · Cited by 52
Parrella, E., & Longo, V. D. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.8 · Cited by 53
Potential of Polyphenols to Restore SIRT1 and NAD+ Metabolism in Renal Disease
Tovar‐Palacio, C., Noriega, L. G., & Mercado, A. (2022) · Nutrients · doi:10.3390/nu14030653 · Cited by 52
Gardner, P. J., Joshi, L., Lee, R., Dick, A. D., Adamson, P., & Calder, V. L. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.01.011 · Cited by 50
Papel de la glía en la enfermedad de Alzheimer. Futuras implicaciones terapéuticas
Cabezas, I. L., Batista, A. H., & Rol, G. P. (2012) · Neurología · doi:10.1016/j.nrl.2012.10.006 · Cited by 50
Targeting histone deacetylases for the treatment of disease
Lawless, M. W., Norris, S., O'Byrne, K. J., & Gray, S. G. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00571.x · Cited by 49
Brain diabetic neurodegeneration segregates with low intrinsic aerobic capacity
Choi, J., Chandrasekaran, K., Demarest, T. G., Kristián, T., Xu, S., Vijaykumar, K., Dsouza, K. G., Qi, N., Yarowsky, P., Gallipoli, R., et al. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.86 · Cited by 52
Ye, F., & Wu, A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210132 · Cited by 50
Malvaso, A., Gatti, A., Negro, G., Calatozzolo, C., Medici, V., & Poloni, T. E. (2023) · Cells · doi:10.3390/cells12242824 · Cited by 54
Sirotkin, A. V., Dekanová, P., Harrath, A. H., Alwasel, S. H., & Vašíček, D. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1940-7 · Cited by 49
Shlomai, J. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.3029 · Cited by 48
The Role of Sirtuin 1 (SIRT1) in Neurodegeneration
Razick, D., Akhtar, M., Wen, J., Alam, M., Dean, N., Karabala, M., Ansari, U., Ansari, Z., Tabaie, E. A., & Siddiqui, S. (2023) · Cureus · doi:10.7759/cureus.40463 · Cited by 48
Yaseen, A. A., Chen, S., Hock, S. K., Rosato, R. R., Dent, P., Dai, Y., & Grant, S. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.079624 · Cited by 50
Dong, Y., Cao, K., Tan, L.-C., Wang, X., Qi, X., Xiao, Y. C., & Guan, Z.-Z. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171020 · Cited by 48
Research progress on sirtuins family members and cell senescence
Wang, T., Wang, Y., Liu, L., Jiang, Z., Li, X., Tong, R., He, J., & Shi, J. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112207 · Cited by 48
Li, J., Long, Q., Ding, H., Wang, Y., Luo, D., Li, Z., & Zhang, W. (2024) · Advanced Science · doi:10.1002/advs.202308677 · Cited by 47
Sirtuins, Bioageing, and Cancer
McGuinness, D. H., McGuinness, D. H., McCaul, J. A., & Shiels, P. G. (2011) · Journal of Aging Research · doi:10.4061/2011/235754 · Cited by 48
Sirtuins and Their Implications in Neurodegenerative Diseases from a Drug Discovery Perspective
Yeong, K. Y., Berdigaliyev, N., & Chang, Y. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00696 · Cited by 46
MicroRNA target prediction in glaucoma
Romano, G. L., Platania, C. B. M., Forte, S., Salomone, S., Drago, F., & Bucolo, C. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.04.013 · Cited by 46
Fonseca‐Santos, B., & Chorilli, M. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119832 · Cited by 47
Sirt1's systemic protective roles and its promise as a target in antiaging medicine
Tang, B. L. (2010) · Translational research · doi:10.1016/j.trsl.2010.11.006 · Cited by 45
Bizat, N., Peyrin, J., Haı̈k, S., Cochois, V., Beaudry, P., Laplanche, J., & Néri, C. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5831-09.2010 · Cited by 46
Andrus, M. B., & Liu, J. (2006) · Tetrahedron Letters · doi:10.1016/j.tetlet.2006.05.065 · Cited by 47
Park, G., Kim, Y., Kang, K., Bae, S., Baek, H., Auh, Q., Chun, Y., Park, B., & Kim, E. (2012) · Journal of Periodontal Research · doi:10.1111/jre.12030 · Cited by 44
Epigenetic Treatment of Neurological Disease
Gray, S. G. (2011) · Epigenomics · doi:10.2217/epi.11.67 · Cited by 45
Zhang, Q., Zhang, P., Qi, G., Zhang, Z., He, F., Lv, Z., Peng, X., Cai, H., Li, T.-X., Wang, X.-M., et al. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.03.021 · Cited by 47
Sirtuins and their interactions with transcription factors and poly(ADP-ribose) polymerases
Jęśko, H. M., & Strosznajder, R. P. (2016) · Folia Neuropathologica · doi:10.5114/fn.2016.62531 · Cited by 44
Xu, N., Huang, F., Jian, C., Qin, L., Lu, F. Y., Wang, Y., Zhang, Z., & Zhang, Q. (2019) · Phytotherapy Research · doi:10.1002/ptr.6335 · Cited by 44
Silva, P., Sureda, A., Tur, J. A., Andreoletti, P., Cherkaoui‐Malki, M., & Latruffe, N. (2019) · Free Radical Research · doi:10.1080/10715762.2019.1614176 · Cited by 46
SIRT1: A promising therapeutic target for chronic pain
Song, F., Liu, D.-Q., Zhou, Y., & Mei, W. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13838 · Cited by 46
Self-citationResveratrol is neuroprotective because it is not a direct activator of Sirt1—A hypothesis
Tang, B. L. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.12.007 · Cited by 48
Arf4 Determines Dentate Gyrus-Mediated Pattern Separation by Regulating Dendritic Spine Development
Jain, S., Yoon, S. Y., Zhu, L., Brodbeck, J., Dai, J., Walker, D., & Huang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046340 · Cited by 43
The role of mitochondrial disturbances in Alzheimer, Parkinson and Huntington diseases
Carvalho, C., Correia, S. C., Cardoso, S., Plácido, A. I., Candeias, E., Duarte, A. I., & Moreira, P. I. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1058160 · Cited by 45
Nada, S. E., Tulsulkar, J., Raghavan, A., Hensley, K., & Shah, Z. A. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.09.013 · Cited by 44
Natural bioactive compounds in Alzheimer's disease: From the perspective of type 3 diabetes mellitus
Huang, J., Huang, N., Mao, Q., Shi, J., & Qiu, Y. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1130253 · Cited by 44
Metadata
- Authors
- Chen, J., Zhou, Y., Mueller-Steiner, S., Chen, L.-F., Kwon, H., Yi, S., Mucke, L., & Gan, L.
- Affiliations
- Gladstone Institutes (US)
- Corresponding author
- Gan, Li
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-12
- Volume
- 280
- Issue
- 48
- Pages
- 40364-40374
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2074916731
- Cited by
- 740
- References
- 54
- Citations by year
- 2026: 13 · 2025: 13 · 2024: 35 · 2023: 36 · 2022: 22 · 2021: 39 · 2020: 49 · 2019: 30 · 2018: 46 · 2017: 40 · 2016: 26 · 2015: 35 · 2014: 35 · 2013: 48 · 2012: 43
- FWCI
- 17.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- University of California, San Francisco
- National Institute of Neurological Disorders and Stroke (NS43945, R01NS043945)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- SIRT1, microglia, amyloid-beta, NF-κB signaling, Alzheimer's disease, neurodegeneration, resveratrol, neuroprotection
- MeSH terms
- Resveratrol, Alzheimer Disease, Animals, Bromodeoxyuridine, Cells, Cultured, Genetic Vectors, Humans, Immunohistochemistry, Lysine, Microscopy, Fluorescence, Models, Biological, Models, Genetic, Neurons, Stilbenes, Signal Transduction, Lentivirus, Amyloid beta-Peptides, NF-kappa B, Rats, Sprague-Dawley, Microglia, Genes, Reporter, Reverse Transcriptase Polymerase Chain Reaction, Sirtuins, Green Fluorescent Proteins, Rats, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review